ITMCTR2000002965
Not yet recruiting
Phase 1
Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic Perfusion
Xianyang Central Hospital0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Xianyang Central Hospital
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •From February 20,2020 to May 31,2022, females aged 18\-55 years, who were diagnosed in the hospital according to the western medicine criteria of sequela of pelvic inflammatory disease and the standards of TCM syndrome of pelvic inflammatory disease of accumulated damp heat according to traditional Chinese medicine.
Exclusion Criteria
- •1\. Patients with severe diseases of heart, liver, kidney and hematopoietic system;
- •2\. Women in pregnancy or to be pregnant in near future or in lactation period;
- •3\. Women who are unable to cooperate, such as those with neurological or mental disorders, or unwilling to cooperate;
- •4\. Those with allergic constitution or multiple drug allergy;
- •5\. Those who have recently used similar drugs for treatment, such as taking drugs with related or antagonistic effects, resulting in difficulty in judging the efficacy of the drugs.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Examinations for immune-biological mechanism of anti-atherosclerotic effects of omega 3 lipid formula, Lotriga, focusing on commensal microbe and serum auto-antibodies.The subjects with hyper-triglyceridemia and atherosclerosis.JPRN-UMIN000032320Yokohama City University Graduate School of Medicine, Department of Medical Science and Cardio-Renal Medicine36
Completed
Not Applicable
Exploratory study on mechanism of action and immune-related biomarkers in patients with salivary gland cancer who received trastuzumab delxtecasalivary gland carcinomaJPRN-UMIN000044278Hokkaido University Hospital Medical oncology52
Not yet recruiting
Phase 4
Mechanism of MIP immunotherapy in multibacillary leprosyHealth Condition 1: A304- Borderline lepromatous leprosyHealth Condition 2: A303- Borderline leprosyHealth Condition 3: A302- Borderline tuberculoid leprosyHealth Condition 4: A305- Lepromatous leprosyHealth Condition 5: A301- Tuberculoid leprosyCTRI/2023/12/060545eprosy Research Initiative (LRI), Netherlands
Completed
Not Applicable
Investigational study on immunomodulatory effect of lenvatinib in clinical specimens - Future oriented approach for lenvatinib on tumor microenvironment and cancer regression (FLORENCE)Hepatocellular carcinomaJPRN-UMIN000044924Hiroshima University50
Not yet recruiting
Not Applicable
The investigation of immunoligical and molecular mecahanisms between obsessive-compulsive disorder and its comorbidity.obsessive-compulsive disorderJPRN-UMIN000046381HYOGO MEDICAL UNIVERSITY200